key: cord-0783255-1tp95yal
authors: Marmiere, Marilena; D'Amico, Filippo; Zangrillo, Alberto; Landoni, Giovanni
title: The five reasons why people die of COVID-19
date: 2021-04-01
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2021.03.045
sha: d0dd55facdab99ce458b121f7f85615c9bc2e7d8
doc_id: 783255
cord_uid: 1tp95yal

nan

Here we want to suggest and outline the reasons and places of COVID-19 deaths, with the aim to clarify the issue.

Organ reserve might be impaired in some people, due to elderly biological age or comorbidities.

For example, a 90-year-old patient with congestive heart failure or severe chronic pulmonary disease dies because even a mild lung involvement causes inadequate oxygenation and multiple organ failure. The median age of patients who died of COVID-19 is 82 years in Italy, 1 meaning that half of them are > 82 years. The only strategy to protect these patients is to prevent SARS-CoV-2 exposure by means of self-isolation. These patients represent the majority of COVID-19 deaths: they usually remain in nursing homes or in hospital wards as a ceiling of treatment and are not admitted to the Intensive Care Unit.

The viral infection itself might be deadly, since SARS-CoV-2 and its pathogenic mechanisms are known to be extremely dangerous. 2 patients' death together with rare acute clinical manifestations (e.g., myocarditis).

In Italy we estimate that patients dying in the ICU accounts for only 18% of the total number of deaths. The mean length of ICU stay was 15 days, with a 50% mortality rate, 6 Authors' contributions all the authors have substantially contributed to the conception of the work, and to the drafting or revision; all the authors have approved the final version and agree to be accountable for all the aspects of the work.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials

Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy

Worldometer's COVID-19 data · Report coronavirus cases